{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:30:07Z","timestamp":1790836207606,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.hrthm.2015.09.010","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T18:01:24Z","timestamp":1442340084000},"page":"443-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":237,"title":["Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications"],"prefix":"10.1016","volume":"13","author":[{"given":"Louise R.A.","family":"Olde Nordkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter G.","family":"Postema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinoud E.","family":"Knops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynke","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Limpens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris R.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2015.09.010_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2015.09.010_bib2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.110.950147","article-title":"Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCEP.112.975268","article-title":"The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention","volume":"6","author":"Olde Nordkamp","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib4","first-page":"e75","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7775\/rac.es.v82.i1.2769","article-title":"Retrospective analysis of patients with Brugada syndrome and implantable cardioverter defibrillator","volume":"82","author":"Abud","year":"2014","journal-title":"Rev Argent Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1540-8167.2004.03388.x","article-title":"Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics","volume":"15","author":"Alexander","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib7","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter-defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib8","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1460-9592.2003.00285.x","article-title":"Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"26","author":"Begley","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jacc.2011.06.043","article-title":"Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention","volume":"58","author":"Bhonsale","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib10","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.amjcard.2012.01.361","article-title":"Congenital long QT 3 in the pediatric population","volume":"109","author":"Blaufox","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00380-006-0963-8","article-title":"Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"22","author":"Boriani","year":"2007","journal-title":"Heart Vessels"},{"key":"10.1016\/j.hrthm.2015.09.010_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/europace\/eut279","article-title":"Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine","volume":"16","author":"Bouzeman","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2015.09.010_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jce.12359","article-title":"Clinical characteristics, management, and prognosis of elderly patients with Brugada syndrome","volume":"25","author":"Conte","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCULATIONAHA.109.913871","article-title":"Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia","volume":"122","author":"Corrado","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib15","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib16","first-page":"8","article-title":"Clinical follow-up of patients with implantable cardioverter-defibrillator","volume":"88","author":"da Fonseca","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jelectrocard.2011.10.002","article-title":"Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry","volume":"45","author":"Daoulah","year":"2012","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jacc.2007.05.042","article-title":"syndrome in children in the era of implantable defibrillators","volume":"50","author":"Etheridge","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome","volume":"58","author":"Giustetto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00246-003-0566-4","article-title":"Implantable cardioverter defibrillator therapy in children with long QT syndrome","volume":"25","author":"Goel","year":"2004","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.hrthm.2008.08.021","article-title":"Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients","volume":"5","author":"Hauser","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jacc.2004.08.068","article-title":"The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)","volume":"45","author":"Hodgkinson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/europace\/eus002","article-title":"Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in Brugada syndrome: a nationwide study","volume":"14","author":"Holst","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2015.09.010_bib24","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.hrthm.2010.08.023","article-title":"Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience","volume":"7","author":"Horner","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib25","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.amjcard.2004.01.057","article-title":"Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy","volume":"93","author":"Jayatilleke","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib26","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00246-013-0676-6","article-title":"Implanted defibrillators in young hypertrophic cardiomyopathy patients: a multicenter study","volume":"34","author":"Kamp","year":"2013","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib27","first-page":"33","article-title":"Mid-term follow-up of patients with Brugada syndrome following a cardioverter defibrillator implantation: a single center experience","volume":"7","author":"Kharazi","year":"2007","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4070\/kcj.2007.37.11.574","article-title":"A clinical observation of patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators","volume":"37","author":"Kim","year":"2007","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1540-8159.2005.09327.x","article-title":"Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy","volume":"28","author":"Lawrenz","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib30","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1540-8167.2011.02288.x","article-title":"Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"23","author":"Li","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/hrt.2008.150656","article-title":"Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy","volume":"95","author":"Lin","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2015.09.010_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1009714718034","article-title":"Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators","volume":"1","author":"Link","year":"1997","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.11622\/smedj.2014055","article-title":"Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand","volume":"55","author":"Makarawate","year":"2014","journal-title":"Singapore Med J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib34","first-page":"537","article-title":"Implantable cardioverter defibrillator and hypertrophic cardiomyopathy: experience at three centers","volume":"59","author":"Marin","year":"2006","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.hrthm.2015.09.010_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2015.09.010_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2015.09.010_bib37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib38","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome","volume":"63","author":"Mazzanti","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib39","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.amjcard.2013.01.295","article-title":"Long-term complications of implantable defibrillator therapy in Brugada syndrome","volume":"111","author":"Miyazaki","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/europace\/eup446","article-title":"A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome","volume":"12","author":"Nakano","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2015.09.010_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/hrt.2010.217182","article-title":"The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy","volume":"98","author":"O\u2019Mahony","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2015.09.010_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2459\/JCM.0b013e32834bed0a","article-title":"Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"13","author":"Peters","year":"2012","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.hrthm.2015.09.010_bib43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2005.03.049","article-title":"Ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up","volume":"107","author":"Pezawas","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib44","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.hrthm.2005.08.022","article-title":"Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia","volume":"2","author":"Piccini","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib45","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0735-1097(98)00037-0","article-title":"Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator","volume":"31","author":"Primo","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/AC.65.5.2056238","article-title":"Incidence of adequate ICD interventions in patients with hypertrophic cardiomyopathy supposed to be at high risk for sudden cardiac death","volume":"65","author":"Prinz","year":"2010","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2013.10.027","article-title":"Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia","volume":"11","author":"Roses-Noguer","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib48","first-page":"435","article-title":"Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU)","volume":"10","author":"Rosso","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib49","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.113.001941","article-title":"Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2","volume":"128","author":"Sacher","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/eurheartj\/ehl450","article-title":"Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome","volume":"28","author":"Sarkozy","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2009.03.136","article-title":"Regional prevalence and clinical benefit of implantable cardioverter defibrillators in Brugada syndrome","volume":"144","author":"Schukro","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib52","doi-asserted-by":"crossref","first-page":"e39584","DOI":"10.1371\/journal.pone.0039584","article-title":"Predictors of appropriate ICD therapy in patients with arrhythmogenic right ventricular cardiomyopathy: long term experience of a tertiary care center","volume":"7","author":"Schuler","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2015.09.010_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3349\/ymj.2014.55.1.37","article-title":"Prognosis after implantation of cardioverter-defibrillators in Korean patients with Brugada syndrome","volume":"55","author":"Son","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib54","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1540-8167.2011.02075.x","article-title":"Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators","volume":"22","author":"Steven","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib55","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"Sy","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib56","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1540-8167.2009.01716.x","article-title":"Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up","volume":"21","author":"Syska","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000350825","article-title":"Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome","volume":"126","author":"Theilade","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.hrthm.2015.09.010_bib58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00392-009-0075-4","article-title":"Prevention of inappropriate ICD shocks in patients with Brugada syndrome","volume":"99","author":"Veltmann","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib60","first-page":"407","article-title":"Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy","volume":"24","author":"Vieira","year":"2005","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib61","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacc.2012.12.025","article-title":"Long-term follow-up of a pediatric cohort with short QT syndrome","volume":"61","author":"Villafane","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib62","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ahj.2013.06.009","article-title":"Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications","volume":"166","author":"Vriesendorp","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib63","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.0000121738.88273.43","article-title":"Implantable cardioverter\/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients","volume":"109","author":"Wichter","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib64","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/hrt.2006.090290","article-title":"Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy","volume":"93","author":"Woo","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2015.09.010_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pcad.2008.10.001","article-title":"Risks and challenges of implantable cardioverter-defibrillators in young adults","volume":"51","author":"Sherrid","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hrthm.2015.09.010_bib66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0002-9149(98)00834-0","article-title":"Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults","volume":"83","author":"Link","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib67","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2010.06.059","article-title":"Inappropriate implantable cardioverter-defibrillator shocks incidence, predictors, and impact on mortality","volume":"57","author":"van Rees","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.hrthm.2004.11.019","article-title":"Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator","volume":"2","author":"Vollmann","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib69","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","article-title":"Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years","volume":"115","author":"Kleemann","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib70","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/CIRCULATIONAHA.110.975219","article-title":"Longevity of sprint fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management","volume":"123","author":"Hauser","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib71","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.hrthm.2011.12.019","article-title":"Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect","volume":"9","author":"Hauser","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.09.010_bib72","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib73","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCEP.108.777888","article-title":"Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005","volume":"1","author":"Al-Khatib","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib74","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archinte.167.7.669","article-title":"Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study","volume":"167","author":"Uslan","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2015.09.010_bib75","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","article-title":"Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry","volume":"122","author":"Poole","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib76","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/CIRCULATIONAHA.106.678664","article-title":"Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study","volume":"116","author":"Klug","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.09.010_bib77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijcard.2012.09.118","article-title":"Lamin A\/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications","volume":"168","author":"van Rijsingen","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib78","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jacc.2013.09.079","article-title":"Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry)","volume":"63","author":"Dodson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib79","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2005.04.063","article-title":"The relation between patients\u2019 outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries","volume":"46","author":"Al-Khatib","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib80","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2015.09.010_bib81","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2013.4598","article-title":"Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial","volume":"309","author":"Gasparini","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2015.09.010_bib82","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jacc.2004.09.039","article-title":"Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms","volume":"44","author":"Theuns","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib83","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jacc.2011.04.039","article-title":"Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry","volume":"58","author":"Dewland","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib84","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib85","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2015.09.010_bib86","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1540-8167.2010.01737.x","article-title":"Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management","volume":"21","author":"Goldenberg","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.09.010_bib87","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527115011777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527115011777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T04:32:11Z","timestamp":1718080331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527115011777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1547527115011777"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2015.09.010","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2015.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}